Structural analysis of neprilysin with various specific and potent inhibitors
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Neutral endopeptidase (NEP) is the major enzyme involved in the metabolic inactivation of a number of bioactive peptides including the enkephalins, substance P, endothelin, bradykinin and atrial natriuretic factor. Owing to the physiological importance of NEP in the modulation of nociceptive and pressor responses, there is considerable interest in inhibitors of this enzyme as novel analgesics and antihypertensive agents. Here, the crystal structures of the soluble extracellular domain of human NEP (residues 52-749) complexed with various potent and competitive inhibitors are described. The structures unambiguously reveal the binding mode of the different zinc-chelating groups and the subsite specificity of the enzyme.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both AutoDock4 and Vina predicted zinc to be coordinated by the carboxylate group, resulting in a misalignment of the ligand with respect to the receptor. The AutoDock4Zn, on the other hand, predicted the proper coordination by sulfanyl and carbonyl groups and provided more accurate FEB estimation.”
From AutoDock4Zn: An Improved AutoDock Force Field for Small-Molecule Docking to Zinc Metalloproteins (2014) · cites this paper as [43]
Citations
Cites
MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures
Kraulis, P. J. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891004399 · Cited by 14,085
[26] Raster3D: Photorealistic molecular graphics
Merritt, E. A., & Bacon, D. J. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)77028-9 · Cited by 3,739
Accurate bond and angle parameters for X-ray protein structure refinement
Engh, R. A., & Huber, R. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767391001071 · Cited by 2,489 · cited 1×
“Iterative rounds of model building were performed with MOLOC (Gerber, 1992) and stereochemically restrained positional and temperature-factor re®nement was performed with REFMAC (Murshudov et al., 1997), using parameters for ideal stereochemistry as described by Engh & Huber (1991).”
MethodFrancis, F., Hennig, S., Korn, B., Reinhardt, R., de Jong, P., Poustka, A., Lehrach, H., Rowe, P. S. N., Goulding, J. N., Summerfield, T., et al. (1995) · Nature Genetics · doi:10.1038/ng1095-130 · Cited by 1,107
Metabolic Regulation of Brain Aβ by Neprilysin
Iwata, N., Tsubuki, S., Takaki, Y., Shirotani, K., Lu, B., Gerard, N. P., Gerard, C., Hama, E., Lee, H.-J., & Saido, T. C. (2001) · Science · doi:10.1126/science.1059946 · Cited by 961 · cited 1×
“More recently, NEP has been implicated in the degradation of amyloid peptide (A 1±42), the primary pathogenic agent in Alzheimer's disease (Shirotani et al., 2001; Iwata et al., 2001).”
BackgroundNeutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology.
Roques, B. P., Noble, F., Daugé, V, Fournié-Zaluski, M. C., & Beaumont, A. (1993) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00449-1 · Cited by 756 · cited 2×
“D60, 392±396 Oefner et al. Neprilysin±inhibitor complexes 393 (Roques et al., 1993).”
BackgroundSelf-citationThe enkephalinase inhibitor thiorphan shows antinociceptive activity in mice
Roques, B. P., Fournié-Zaluski, M. C., Soroca, E., Lecomte, J. M., Malfroy, B., Llorens, C., & Schwartz, J.-C. (1980) · Nature · doi:10.1038/288286a0 · Cited by 705 · cited 1×
“NEP has been implicated in the regulation of opioid peptide action through the degradation of endogenously released enkephalins (Roques et al., 1980).”
BackgroundSelf-citationStructural basis of the action of thermolysin and related zinc peptidases
Matthews, B. W. (1988) · Accounts of Chemical Research · doi:10.1021/ar00153a003 · Cited by 687 · cited 2×
“The catalytic properties of NEP resemble those of a group of zinc-dependent bacterial endopeptidases, of which thermolysin (TLN) is the best characterized (Matthews, 1988).”
BackgroundEmoto, N., & Yanagisawa, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.25.15262 · Cited by 499 · cited 2×
“…years, several mammalian homologues of NEP have been described, including the endothelin-converting enzymes ECE-1 (Shimada et al., 1994) and ECE-2 (Emoto & Yanagisawa, 1995), the erythrocyte surface antigen KELL (Lee et al., 1991), the phosphate-regulating gene (PEX) on the X chromosome (HYP…”
BackgroundThe purification and specificity of a neutral endopeptidase from rabbit kidney brush border
Kerr, M. A., & Kenny, A. J. (1974) · Biochemical Journal · doi:10.1042/bj1370477 · Cited by 460 · cited 1×
“NEP was originally extracted and puri®ed from the brush border of rabbit kidney as a peptidase capable of hydrolyzing the insulin B chain (Kerr & Kenny, 1974).”
Method
Cited by
Diverse, High-Quality Test Set for the Validation of Protein−Ligand Docking Performance
Hartshorn, M. J., Verdonk, M. L., Chessari, G., Brewerton, S. C., Mooij, W. T. M., Mortenson, P. N., & Murray, C. W. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061277y · Cited by 625
Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease
Barage, S. H., & Sonawane, K. D. (2015) · Neuropeptides · doi:10.1016/j.npep.2015.06.008 · Cited by 579
“NEP is a zinc dependent endopeptidase which cleaves peptides within hydrophobic residues (Turner et al., 2001; Oefner et al., 2004).”
InfluentialArendse, L. B., Danser, A. H. J., Poglitsch, M., Touyz, R. M., Burnett, J. C., Llorens-Cortes, C., Ehlers, M. R., & Sturrock, E. D. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.017129 · Cited by 339
“There is also accumulating evidence that additional receptors, including AT 2 R (Walters et al., 2005; Ohshima et al., 2014; Shimada et al., 2015) and Mas-related GPCR member D (Gembardt et al., 2008; Lautner et al., 2013; Tetzner et al., 2016), can function as Ang 1-7 receptors and that receptors…”
AutoDock4Zn: An Improved AutoDock Force Field for Small-Molecule Docking to Zinc Metalloproteins
Santos-Martins, D., Forli, S., Ramos, M. J., & Olson, A. J. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci500209e · Cited by 318
Targeting Metalloenzymes for Therapeutic Intervention
Chen, A. Y., Adamek, R. N., Dick, B. L., Credille, C. V., Morrison, C. N., & Cohen, S. M. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00201 · Cited by 270
Human peripheral blood B‐cell compartments: A crossroad in B‐cell traffic
Perez‐Andres, M., Paiva, B., Nieto, W. G., Caraux, A., Schmitz, A., Almeida, J., Vogt, R. F., Marti, G. E., Rawstron, A. C., Van Zelm, M. C., et al. (2010) · Cytometry Part B: Clinical Cytometry · doi:10.1002/cyto.b.20547 · Cited by 270
Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain
Roques, B. P., Fournié-Zaluski, M.-C., & Wurm, M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3673 · Cited by 194
“To this end, the structure of the metabolizing enzymes in complex with an inhibito”
BackgroundSelf-citationAmyloid β-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin
Malito, E., Hulse, R. E., & Tang, W.-J. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8112-4 · Cited by 176
Jha, N. K., Jha, S. K., Kumar, D., Kejriwal, N., Sharma, R., Ambasta, R. K., & Kumar, P. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150379 · Cited by 96
“subunit as a cofactor for its catalytic activity [39–41].”
BackgroundMultifunctional roles of zinc in Alzheimer’s disease
Xie, Z., Wu, H., & Zhao, J. (2020) · NeuroToxicology · doi:10.1016/j.neuro.2020.07.003 · Cited by 89
The MEROPS batch BLAST: A tool to detect peptidases and their non-peptidase homologues in a genome
Rawlings, N. D., & Morton, F. R. (2007) · Biochimie · doi:10.1016/j.biochi.2007.09.014 · Cited by 77
Dieterich, K. D., Quijano-Roy, S., Monnier, N., Zhou, J., Fauré, J., Avila‐Smirnow, D., Carlier, R., Laroche, C., Marcorelles, P., Mercier, S., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds514 · Cited by 75
Webster, C. I., Burrell, M. R., Olsson, L., Fowler, S. A., Digby, S., Sandercock, A. M., Snijder, A., Tebbe, J., Haupts, U. M., Grudzinska, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104001 · Cited by 73
“While structures of NEP in complex with different inhibitors display similar main-chain conformation, large ligand induced flexibility is observed for the side chains that form the substrate binding pockets (such as Arg(102), Phe(106), Arg(110) and Trp(693)), which may explain the broad substrate specificity of the en…”
BackgroundStructure of neprilysin in complex with the active metabolite of sacubitril
Schiering, N., D'Arcy, A., Villard, F., Ramage, P., Logel, C., Cumin, F., Ksander, G. M., Wiesmann, C., Karki, R. G., & Mogi, M. (2016) · Scientific Reports · doi:10.1038/srep27909 · Cited by 72
Pankow, K., Schwiebs, A., Becker, M., Siems, W., Krause, G., & Walther, T. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.08.025 · Cited by 59
Structure of human Endothelin-converting Enzyme I Complexed with Phosphoramidon
Schulz, H., Dale, G. E., Karimi‐Nejad, Y., & Oefner, C. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.10.052 · Cited by 55
Self-citationCuII Binding Properties of N-Truncated Aβ Peptides: In Search of Biological Function
Stefaniak, E., & Bal, W. (2019) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.9b01399 · Cited by 62
New Orally Active Dual Enkephalinase Inhibitors (DENKIs) for Central and Peripheral Pain Treatment
Poras, H., Bonnard, E., Dangé, E., Fournié‐Zaluski, M., & Roques, B. P. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500602h · Cited by 56
Self-citationThomas, J. E., Rylett, C. M., Çarhan, A., Bland, N. D., Bingham, R. J., Shirras, A. D., Turner, A. J., & Isaac, R. E. (2005) · Biochemical Journal · doi:10.1042/bj20041753 · Cited by 44
Ferraris, D. M., Sbardella, D., Petrera, A., Marini, S., Amstutz, B., Coletta, M., Sander, P., & Rizzi, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.271809 · Cited by 41
Interplay between Copper, Neprilysin, and N-Truncation of β-Amyloid
Mital, M., Bal, W., Frączyk, T., & Drew, S. C. (2018) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.8b00391 · Cited by 35
Sahli, S., Frank, B., Schweizer, W. B., Diederich, F., Blum‐Kaelin, D., Aebi, J. D., Böhm, H., Oefner, C., & Dale, G. E. (2005) · Helvetica Chimica Acta · doi:10.1002/hlca.200590051 · Cited by 33
Self-citationA New Class of Inhibitors for the Metalloprotease Neprilysin Based on a Central Imidazole Scaffold
Sahli, S., Stump, B., Welti, T., Schweizer, W. B., Diederich, F., Blum‐Kaelin, D., Aebi, J. D., & Böhm, H. (2005) · Helvetica Chimica Acta · doi:10.1002/hlca.200590050 · Cited by 36
Hayashi, T., Matsuzaki, Y., Yanagisawa, K., Ohue, M., & Akiyama, Y. (2018) · BMC Bioinformatics · doi:10.1186/s12859-018-2073-x · Cited by 30
“Here, 1R1H [48] describes the complex structure of MME and an inhibitor, and 1A4I [49] describes a homodimer complex structure of MTHFD1.”
BackgroundSwapping the Substrate Specificities of the Neuropeptidases Neurolysin and Thimet Oligopeptidase
Lim, E. J., Sampath, S., Coll-Rodriguez, J., Schmidt, J., Ray, K., & Rodgers, D. W. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609897200 · Cited by 31
Meyer, H., Panz, M., Zmojdzian, M., Jagla, K., & Paululat, A. (2009) · Journal of Experimental Biology · doi:10.1242/jeb.034272 · Cited by 36
“…and inhibitor sensitivity (Whyteside and Turner, 2008), a comparison of the amino acid residues that line the hydrophobic pockets of human NEP (Oefner et al., 2000; Oefner et al., 2004) and human NEP2 (Whyteside and Turner, 2008) showed identical ligand binding S1 and S2 subsites (Table1).”
BackgroundCozier, G. E., Arendse, L. B., Schwager, S. L. U., Sturrock, E. D., & Acharya, K. R. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01309 · Cited by 32
Proteomic Analysis (GeLC–MS/MS) of ePFT-Collected Pancreatic Fluid in Chronic Pancreatitis
Paulo, J. A., Kadiyala, V., Lee, L., Banks, P. A., Conwell, D. L., & Steen, H. (2012) · Journal of Proteome Research · doi:10.1021/pr2011022 · Cited by 26
High resolution crystal structure of substrate-free human neprilysin
Moss, S., Subramanian, V., & Acharya, K. R. (2018) · Journal of Structural Biology · doi:10.1016/j.jsb.2018.06.004 · Cited by 25
“To date, eight inhibitor bound crystal structures of NEP extracellular domain are currently available in the Protein Data Bank.”
BackgroundInfluentialDeaton, D. N., Gao, E. N., Graham, K. P., Gross, J. W., Miller, A. B., & Strelow, J. M. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.11.048 · Cited by 25
A Three-dimensional Model of the Neprilysin 2 Active Site Based on the X-ray Structure of Neprilysin
Voisin, S., Rognan, D., Gros, C., & Ouimet, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407333200 · Cited by 23
Morgenthaler, M., Aebi, J. D., Grüninger, F., Mona, D., Wagner, B., Kansy, M., & Diederich, F. (2008) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2008.02.004 · Cited by 26
Replacement of the C-terminal Trp-cage of exendin-4 with a fatty acid improves therapeutic utility
Lee, J. G., Ryu, J. H., Kim, S.-M., Park, M. Y., Kim, S.-H., Shin, Y. G., Sohn, J., Kim, H. H., Park, Z., Seong, J. Y., et al. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.03.004 · Cited by 23
Crystal structure of peptide‐bound neprilysin reveals key binding interactions
Moss, S., Subramanian, V., & Acharya, K. R. (2019) · FEBS Letters · doi:10.1002/1873-3468.13602 · Cited by 22
Zhang, X., Hu, C., Tian, E., Shen, Y., Liu, W. Y., & Li, J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1501407 · Cited by 25
Ortiz, C., Klein, S., Reul, W., Magdaleno, F., Gröschl, S., Dietrich, P., Schierwagen, R., Uschner, F. E., Torres, S., Hieber, C., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112059 · Cited by 22
Copper Transporters? Glutathione Reactivity of Products of Cu–Aβ Digestion by Neprilysin
Stefaniak, E., Płonka, D., Szczerba, P., Wezynfeld, N. E., & Bal, W. (2020) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.0c00427 · Cited by 24
Rosa, M., Arsequell, G., Rougeot, C., Calle, L. P., Marcelo, F., Pinto, M., Centeno, N. B., Jiménez‐Barbero, J., & Valencia, G. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm2012112 · Cited by 19
Zhang, S., Raedschelders, K., Santos, M., & Van Eyk, J. E. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00482 · Cited by 19
Deaton, D. N., Graham, K. P., Gross, J. W., & Miller, A. B. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.01.046 · Cited by 16
A Labeled Neutral Endopeptidase Inhibitor as a Potential Tool for Tumor Diagnosis and Prognosis
Raguin, O., Fournié‐Zaluski, M., Romieu, A., Pèlegrin, A., Chatelet, F., Pélaprat, D., Barbet, J., Roques, B. P., & Gruaz‐Guyon, A. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200500700 · Cited by 13
Self-citationGM-DockZn: a geometry matching-based docking algorithm for zinc proteins
Wang, K., Lyu, N., Diao, H., Jin, S., Zeng, T., Zhou, Y., & Wu, R. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa292 · Cited by 16
Roques, B. P. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_17 · Cited by 12
Self-citationAloysius, H., & Hu, L. (2020) · Medicinal Chemistry Research · doi:10.1007/s00044-020-02573-w · Cited by 11
Du, C., Wang, S., Shi, X., Jing, P., Wang, H., & Wang, L. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108901 · Cited by 11
Arendse, L. B., Cozier, G. E., Eyermann, C. J., Basarab, G. S., Schwager, S. L. U., Chibale, K., Acharya, K. R., & Sturrock, E. D. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01924 · Cited by 11
“Crystal structures of NEP in complex with a range of inhibitors have been reported previously.(45-47) While the Cα backbones of these structures overlay closely, residue sidechains of Tyr693 and Phe106 which separate the S1ʹ and S2ʹ subsites as well as Arg102 and Arg110, adopt different orientations depending on the s…”
BackgroundPope, D., Madura, J. D., & Cascio, M. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci500015m · Cited by 11
Proposed Bioactive Conformations of Opiorphin, an Endogenous Dual APN/NEP Inhibitor
Pinto, M., Rougeot, C., Gracia, L., Rosa, M., Garcı́a, A., Arsequell, G., Valencia, G., & Centeno, N. B. (2011) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200182v · Cited by 10
Sobocińska, M. K., Giełdoń, A., Fichna, J., & Kamysz, E. (2018) · Amino Acids · doi:10.1007/s00726-018-2585-8 · Cited by 9
“As it was pointed previously (Oefner et al. 2004; Misawa et al. 2011) and also as was found in the 2QPJ PDB structure, the residue located at the S1′ binding pocket should be hydrophobic.”
The Drosophila melanogaster Neprilysin Nepl15 is involved in lipid and carbohydrate storage
Banerjee, S. J., Woods, C., Burnett, M., Park, S. J., Ja, W. W., & Curtiss, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-81165-z · Cited by 11
Velliquette, R. W., Hue‐Roye, K., Lomas, C., Gillen, B., Schierts, J., Gentzkow, K., Peyrard, T., von Zabern, I., Flegel, W. A., Rodberg, K., et al. (2013) · Transfusion · doi:10.1111/trf.12200 · Cited by 8
Structure-Guided Design of Substituted Biphenyl Butanoic Acid Derivatives as Neprilysin Inhibitors
Kawanami, T., Karki, R. G., Cody, E., Liu, Q., Liang, G., Ksander, G. M., Rigel, D. F., Schiering, N., Gong, Y., Coppola, G. M., et al. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00578 · Cited by 8
Ouimet, T., Orng, S., Poras, H., Gagnidze, K., Devi, L., Fournie-Zaluski, M., & Roques, B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.120576 · Cited by 9
Self-citationPoras, H., Ouimet, T., Orng, S.-V., Dangé, E., Fournié‐Zaluski, M., & Roques, B. P. (2011) · Analytical Biochemistry · doi:10.1016/j.ab.2011.08.016 · Cited by 7
“Indeed, the results show that NEP-2 prefers a hydrophobic aliphatic side chain in S1 and an aromatic side chain in S2 whereas NEP-1 preferred an aromatic residue in S1 and a small residue in S2 positions, respectively [50,51].”
BackgroundSelf-citationStructures of soluble rabbit neprilysin complexed with phosphoramidon or thiorphan
Labiuk, S. L., SYGUSCH, J., & Grochulski, P. (2019) · Acta Crystallographica Section F Structural Biology Communications · doi:10.1107/s2053230x19006046 · Cited by 7
Asadi, M., Mohammadi‐Khanaposhtani, M., Hosseini, F. S., Gholami, M., Dehpour, A. R., & Amanlou, M. (2021) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.319573 · Cited by 7
“The NEP crystal structure as receptor was retrieved from a protein data bank with PDB ID: 1R1H (29).”
MethodInfluentialA multilayer dynamic perturbation analysis method for predicting ligand–protein interactions
Gu, L., Ли, Б., & Ming, D. (2022) · BMC Bioinformatics · doi:10.1186/s12859-022-04995-2 · Cited by 6
“4, PDB code: 1R1H[71]).”
Sobocińska, M. K., Fichna, J., Giełdoń, A., Skowron, P. M., & Kamysz, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214450 · Cited by 6
Poras, H., Bonnard, E., Fournié‐Zaluski, M., & Roques, B. P. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.07.027 · Cited by 5
Self-citationEffects of human opiorphin on food intake and water intake in mice following central administration
Chen, Y., Tian, X., Bai, L., Liu, Z.-Q., Xiao, X., Liu, P., & Li, X.-K. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.01.028 · Cited by 5
Holmes, R. S. (2013) · Journal of Phylogenetics & Evolutionary Biology · doi:10.4172/2329-9002.1000112 · Cited by 4
Sacubitril/Valsartan: A New Dawn has Begun! A Revisited Review
Abdelnabi, M. H., Saleh, Y., Almaghraby, A. M., Girgis, H., & Gerges, F. (2021) · Current Cardiology Reviews · doi:10.2174/1573403x17666210831142452 · Cited by 5
Endogenous Opioids and the Treatment of Multiple Sclerosis
McLaughlin, P. J. (2013) · Journal of Neurology & Neurophysiology · doi:10.4172/2155-9562.s12-011 · Cited by 4
“Neprilysin actively degrades a number of signaling neuropeptides including enkephalins, substance P, and atrial natriuretic factor [26-29], thus implicating a role of aberrant levels of endogenous opioids and/or their enkephalinases in disease.”
BackgroundNeprilysin 4: an essential peptidase with multifaceted physiological relevance
Buhr, A., Schiemann, R., & Meyer, H. (2023) · Biological Chemistry · doi:10.1515/hsz-2022-0286 · Cited by 5
The tripartite architecture of the eukaryotic integral membrane protein zinc metalloprotease Ste24
Goblirsch, B. R., Pryor, E. E., & Wiener, M. C. (2019) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25841 · Cited by 5
“53, 54 For all four structural homologs, S1 0 forms a hydrophobic pocket ( Figure 2 ).”
BackgroundNolasco, M., Mariano, D. O. C., Pimenta, D. C., de Freitas, H. F., Pita, S. S. D. R., & Branco, A. (2024) · Peptide Science · doi:10.1002/pep2.24347 · Cited by 3
Substituted α-mercaptoketones, new types of specific neprilysin inhibitors
Poras, H., Patouret, R., Leiris, S. J., Ouimet, T., Fournié‐Zaluski, M., & Roques, B. P. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.06.050 · Cited by 3
Self-citationRao, N. K., Yadav, A., & Singh, S. K. (2009) · Journal of Molecular Modeling · doi:10.1007/s00894-009-0500-7 · Cited by 2
Ul‐Haq, Z., Usmani, S., Iqbal, S., & Zia, S. R. (2016) · Molecular BioSystems · doi:10.1039/c5mb00727e · Cited by 2
Cozier, G. E., Coulson, L. B., Eyermann, C. J., Basarab, G. S., Schwager, S. L. U., Chibale, K., Sturrock, E. D., & Acharya, K. R. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00329 · Cited by 2
Neprilysin, a Multifunctional Peptidase: Molecular Functions and Roles in Human Disease
Gharechahi, J. (2026) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-026-10819-1 · Cited by 1
“It exhibits broad substrate specificity, capable of cleaving a wide range of peptide substrates, including natriuretic peptides (NPs), bombesin-like peptides, bradykinin, substance P, enkepha - lins, endothelins, angiotensins, glucagon, insulin, and amy - loid-beta (Aβ) (Oefner et al. 2004).”
Ligand-based drug design for human endothelin converting enzyme-1 inhibitors
Tanneeru, K., Sahu, I., & Guruprasad, L. (2013) · Medicinal Chemistry Research · doi:10.1007/s00044-012-0433-z · Cited by 1
“Some neprilysin family proteins (example: PDB_IDS: 1DMT, 1R1J, and 1Y8J) have sulfur and/or oxygen atoms of inhibitors in contact with Zn-ion indicating the importance of the electronegative group in this location (Oefner et al., 2000; Oefner et al., 2004; Sahli et al., 2005).”
BackgroundNeprilysin Inhibitors Provide Insight into its Specificity and Therapeutic Potential
Pope, D., & Cascio, M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-803959-5.50013-1 · Cited by 1
Nieto, W. G. (2012) · Gredos (University of Salamanca) · doi:10.14201/gredos.121199 · Cited by 1
STRUCTURAL AND FUNCTIONAL STUDIES OF SYNAPTIC ENZYMES
Lim, E. J. (2006) · UKnowledge (University of Kentucky)
A Labeled Neutral Endopeptidase Inhibitor as a Potential Tool for Tumor Diagnosis and Prognosis
Raguin, O., Fournié‐Zaluski, M., Romieu, A., Pèlegrin, A., Chatelet, F., Pélaprat, D., Barbet, J., Roques, B. P., & Gruaz‐Guyon, A. (2005) · Angewandte Chemie · doi:10.1002/ange.200500700
Self-citationEl-Bahrawy, M. A. (2023) · Essentials of Diagnostic Gynecological Pathology. · doi:10.1007/978-3-031-39659-5_14 · Cited by 1
Schiemann, R., & Meyer, H. (2025) · Handbook of Proteolytic Enzymes · doi:10.1016/b978-0-443-28849-4.00062-x
Gu, L., Li, B., & Ming, D. (2022) · Figshare · doi:10.6084/m9.figshare.21485795
BindingDB (2013) · UC San Diego · doi:10.7270/q2p84cz6
BindingDB Entry 50001081: Substitutedα-mercaptoketones, new types of specific neprilysin inhibitors.
BindingDB (2020) · UC San Diego · doi:10.7270/q20v8g93
Metadata
- Authors
- Oefner, C., Roques, B. P., Fournie-Zaluski, M.-C., & Dale, G. E.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- ORCID
- Dale, Glenn E.
- Venue
- Acta Crystallographica Section D Biological Crystallography
- Published
- 2004-01-24
- Volume
- 60
- Issue
- 2
- Pages
- 392-396
- ISSN
- 0907-4449 (ISSN-L)
- OpenAlex
- W2053884159
- Cited by
- 81
- References
- 23
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 3 · 2023: 3 · 2022: 4 · 2021: 3 · 2020: 5 · 2019: 5 · 2018: 7 · 2017: 3 · 2016: 3 · 2015: 3 · 2014: 5 · 2013: 5 · 2012: 5
- FWCI
- 2.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.iucr.org/services/copyrightpolicy.html (vor)
- journals.iucr.org/services/copyrightpolicy.html#TDM (tdm)
- Locations
- Acta Crystallographica Section D Biological Crystallography (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Peptidase Inhibition and Analysis
- Keywords
- neprilysin, neutral endopeptidase, enzyme inhibitors, competitive inhibitors, analgesics, antihypertensive drugs, extracellular domain
- MeSH terms
- Binding, Competitive, Electrons, Enkephalins, Humans, Models, Chemical, Models, Molecular, Peptides, Protein Binding, Zinc, Neprilysin, Protein Structure, Tertiary, Crystallography, X-Ray
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.